Molecular Profiling of Inflammatory Processes in a Mouse Model of IC/BPS: From the Complete Transcriptome to Major Sex-Related Histological Features of the Urinary Bladder.
Dominika PeskarTadeja KuretKatja LakotaAndreja ErmanPublished in: International journal of molecular sciences (2023)
Animal models are invaluable in the research of the pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic aseptic urinary bladder disease of unknown etiology that primarily affects women. Here, a mouse model of IC/BPS was induced with multiple low-dose cyclophosphamide (CYP) applications and thoroughly characterized by RNA sequencing, qPCR, Western blot, and immunolabeling to elucidate key inflammatory processes and sex-dependent differences in the bladder inflammatory response. CYP treatment resulted in the upregulation of inflammatory transcripts such as Ccl8 , Eda2r , and Vegfd , which are predominantly involved in innate immunity pathways, recapitulating the crucial findings in the bladder transcriptome of IC/BPS patients. The JAK/STAT signaling pathway was analyzed in detail, and the JAK3/STAT3 interaction was found to be most activated in cells of the bladder urothelium and lamina propria. Sex-based data analysis revealed that cell proliferation was more pronounced in male bladders, while innate immunity and tissue remodeling processes were the most distinctive responses of female bladders to CYP treatment. These processes were also reflected in prominent histological changes in the bladder. The study provides an invaluable reference dataset for preclinical research on IC/BPS and an insight into the sex-specific mechanisms involved in the development of IC/BPS pathology, which may explain the more frequent occurrence of this disease in women.
Keyphrases
- single cell
- spinal cord injury
- mouse model
- low dose
- cell proliferation
- signaling pathway
- data analysis
- inflammatory response
- oxidative stress
- rna seq
- urinary tract
- induced apoptosis
- end stage renal disease
- gene expression
- ejection fraction
- risk assessment
- pi k akt
- newly diagnosed
- polycystic ovary syndrome
- genome wide
- drug induced
- epithelial mesenchymal transition
- high dose
- type diabetes
- pregnancy outcomes
- chronic kidney disease
- combination therapy
- liver injury
- cell death
- stem cells
- mesenchymal stem cells
- patient reported outcomes
- south africa
- toll like receptor
- african american
- single molecule
- cell cycle arrest
- peritoneal dialysis
- liver fibrosis